Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology: Living and Learning With Advancing AD

NCT04335110 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04335110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology: Living and Learning With Advancing AD
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Completed
Start date
March 24, 2021
Completion date
June 15, 2023
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, caregiver burnout, dementia, family members